Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
desloratadin "sun" 5 mg filmovertrukne tabletter
sun pharma france - desloratadin - filmovertrukne tabletter - 5 mg
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
paroex 1,2 mg/ml mundskyllevæske
sunstar france - chlorhexidindigluconat-opløsning (20%) - mundskyllevæske - 1,2 mg/ml
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
telfast 30 mg filmovertrukne tabletter
opella healthcare france sas - fexofenadinhydrochlorid - filmovertrukne tabletter - 30 mg
Denmark -
Danish -
SEGES Landbrug & Fødevarer
smartfresh vp pulver
agrofresh holding france s.a.s. - 1-methylcyclopropen - pulver - 33 g/kg 1-methylcyclopropen
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
maltofer 50 mg/ml orale dråber, opløsning
vifor france - ferrihydroxid polymaltose komplex - orale dråber, opløsning - 50 mg/ml
Denmark -
Danish -
Lægemiddelstyrelsen (Danish Medicines Agency)
maltofer 100 mg tyggetabletter
vifor france - ferrihydroxid polymaltose komplex - tyggetabletter - 100 mg
European Union -
Danish -
EMA (European Medicines Agency)
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosuppressiva - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
European Union -
Danish -
EMA (European Medicines Agency)
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - alle andre terapeutiske produkter - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
European Union -
Danish -
EMA (European Medicines Agency)
pylclari
curium pet france - piflufolastat (18f) - prostatiske neoplasmer - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
Denmark -
Danish -
SEGES Landbrug & Fødevarer
bumper 25 ec emulsionskoncentrat
adama northern europe b.v. - propiconazol - emulsionskoncentrat - 250 g/l propiconazol